Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

Thanks for your response to my post inside...I agree that the company may surprise us with an upside to the Q4 numbers...And if we see a further decline, God help them.

The best upside PR I can imagine would read as follows:

December 1, 2014

MEDICAL NEWS TODAY

"Larson terminated by Navidea for cause"

After more than a decade of financial missteps and financial chaos at Navidea (formerly Neoprobe) the BOD has decided to terminate CFO Brent Larson immediately. The termination is with cause and because of such, no severance bonus like the $750K that Mark Pykett received earlier in the year will be paid. "Under no circumstances will this company feed the Brent Larson family any longer. He has destroyed shareholder value in excess of $175 million and has worked against the company's objectives repeatedly to the extent that the company plans to fight his ability to even collect unemployment insurance from the state of Ohio." said current CEO Rick Gonzalez. Gonzalez went on to say, "The Navidea shareholder has been abused and mistreated since the Crede deal. The company is intent on fixing this disgrace and is presently talking with three major pharmaceuticals that are each showing major interest in partnering with Navidea on our Manocept platform."

If this PR couldn't move the pps, nothing could!

GLTA.